2025
SJR Q2
JCR Q2 · 3,5
15 eşleşen makale
SCIE
Dergi ayrıntısı
Molecular Carcinogenesis
- Yayıncı
- Wiley-Liss Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0899198710982744
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,048
- Quartile Q2
- H-Index 114
- Atıf/yayın 3,54
- Doküman (3y) 418
- Atıf (3y) 1.507
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,5
- 5Y JIF 3,6
- JCI 0,72
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cancer Research Q2
- Molecular Biology Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
WoS kategorileri
- Biochemistry & Molecular Biology | Oncology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 1,048 | 3,5 | 3,6 | 0,72 | Q2 | 114 |
| 2024 | Q2 | Q2 | 0,949 | 3,2 | 3,5 | 0,73 | Q2 | 110 |
| 2023 | Q2 | Q2 | 1,034 | 3 | 3,8 | 0,8 | Q2 | 110 |
| 2022 | Q2 | Q2 | 1,022 | 4,6 | 4,1 | 0,85 | Q2 | 110 |
| 2021 | Q2 | Q2 | 1,075 | 5,1 | 4,6 | 0,95 | Q2 | 110 |
| 2020 | Q2 | Q2 | 1,254 | 4,8 | 4,4 | 1 | Q1 | 110 |
| 2019 | Q2 | Q2 | 1,277 | 3,8 | 3,6 | 1,04 | Q1 | 110 |
| 2018 | — | Q2 | — | 3,4 | 3,3 | 1,08 | Q1 | — |
| 2017 | Q2 | Q2 | 1,277 | 3,9 | 3,7 | 1,11 | Q1 | 110 |
| 2016 | Q2 | Q1 | 1,317 | 4,2 | 4 | — | — | 110 |
| 2015 | Q2 | Q1 | 1,453 | 4,7 | 3,9 | — | — | 110 |
| 2014 | Q2 | Q1 | 1,656 | 4,8 | 4,2 | — | — | 110 |
| 2013 | Q2 | Q1 | 1,761 | 4,8 | 3,9 | — | — | 110 |
| 2012 | Q2 | Q1 | 1,523 | 4,3 | 3,5 | — | — | 110 |
| 2011 | Q2 | Q2 | 1,41 | 3,2 | 3,1 | — | — | 110 |
| 2010 | Q2 | Q2 | 1,689 | 3,3 | 3,3 | — | — | 110 |
| 2009 | — | Q2 | — | 3,2 | 3,1 | — | — | — |
| 2008 | — | Q2 | — | 3,6 | 3,1 | — | — | — |
| 2007 | — | Q2 | — | 3,2 | 3 | — | — | — |
| 2006 | — | Q2 | — | 2,7 | — | — | — | — |
| 2005 | — | Q2 | — | 2,4 | — | — | — | — |
| 2004 | — | Q2 | — | 3 | — | — | — | — |
| 2003 | — | Q2 | — | 2,8 | — | — | — | — |
| 2002 | — | Q2 | — | 2,8 | — | — | — | — |
| 2001 | — | Q1 | — | 3,3 | — | — | — | — |
| 2000 | — | Q1 | — | 3,1 | — | — | — | — |
| 1999 | — | Q2 | — | 2,6 | — | — | — | — |
| 1998 | — | Q2 | — | 2,3 | — | — | — | — |
| 1997 | — | Q1 | — | 2,7 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 163/328 |
| 2025 | ONCOLOGY | SCIE | Q2 | Q2 | 142/333 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 151/320 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q2 | 130/328 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q2 | 171/313 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q2 | 142/322 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 97/285 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 89/241 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 103/297 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 89/245 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 97/295 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 98/242 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q2 | 108/297 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q1 | 95/244 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 119/299 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q1 | 95/230 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 83/293 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q1 | 79/223 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 72/290 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 61/217 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 58/289 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 42/213 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 55/290 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 36/211 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | — | 62/291 |
| 2013 | ONCOLOGY | SCIE | Q1 | — | 43/203 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 73/290 |
| 2012 | ONCOLOGY | SCIE | Q1 | — | 48/197 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 120/290 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 74/196 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 118/286 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 63/185 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 104/283 |
| 2009 | ONCOLOGY | SCIE | Q2 | — | 59/166 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 88/275 |
| 2008 | ONCOLOGY | SCIE | Q2 | — | 49/143 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 101/263 |
| 2007 | ONCOLOGY | SCIE | Q2 | — | 52/132 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 118/262 |
| 2006 | ONCOLOGY | SCIE | Q2 | — | 55/127 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 128/261 |
| 2005 | ONCOLOGY | SCIE | Q3 | — | 62/123 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 99/261 |
| 2004 | ONCOLOGY | SCIE | Q2 | — | 47/123 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 98/261 |
| 2003 | ONCOLOGY | SCIE | Q2 | — | 45/120 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 98/266 |
| 2002 | ONCOLOGY | SCIE | Q2 | — | 37/114 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 85/308 |
| 2001 | ONCOLOGY | SCIE | Q1 | — | 26/107 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 87/310 |
| 2000 | ONCOLOGY | SCIE | Q1 | — | 21/103 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 99/295 |
| 1999 | ONCOLOGY | SCIE | Q2 | — | 30/105 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 101/295 |
| 1998 | ONCOLOGY | SCIE | Q2 | — | 29/104 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 75/253 |
| 1997 | ONCOLOGY | SCIE | Q1 | — | 20/102 |